Literature DB >> 21633846

Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.

Masaya Tamura1, Makoto Oda, Isao Matsumoto, Yosuke Shimizu, Ryuichi Waseda, Go Watanabe.   

Abstract

BACKGROUND: The aim of this study was to analyze parameters to predict tumor invasiveness according to high-resolution computed tomography and positron emission tomography in patients with clinical stage IA lung adenocarcinoma.
METHODS: A total of 122 patients with clinical stage IA lung adenocarcinoma were enrolled in the study. Receiver operating characteristic (ROC) curves were constructed for three factors--the degree of solid tumor component (solid%), maximum standard uptake value (SUVmax) and tumor size--and cutoff values were determined to reveal the highest sensitivity and specificity to diagnose tumor invasiveness. We created an algorithm for detecting tumor invasiveness (model 1). The data for the three factors were combined and their ROC curves constructed (model 2). A prospective study was conducted to validate the utility of these models.
RESULTS: Multivariate analysis identified solid%, SUVmax, and tumor size as potentially important predictors of tumor invasiveness. In the ROC curve analysis, solid% (area under the curve was 0.882) had the largest area under the curve, followed by the SUV (0.867) and tumor size (0.747). The combination assay using all three factors had the highest sensitivity and specificity for prediction (0.902). Models 1 and 2 were applied to the prospectively enrolled cases, and their utility was reviewed. Both models showed 100% sensitivity, with model 2 showing a slightly higher diagnostic value than model 1.
CONCLUSIONS: The solid portion ratio was a more powerful clinical predictor for lymphovascular invasion than the SUVmax. Our novel scoring model for tumor invasiveness can be employed for preoperative assessment of tumor invasiveness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21633846     DOI: 10.1007/s00268-011-1145-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

2.  Intentional limited resection for selected patients with T1 N0 M0 non-small-cell lung cancer: a single-institution study.

Authors:  K Kodama; O Doi; M Higashiyama; H Yokouchi
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

3.  Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  K Takamochi; K Nagai; J Yoshida; K Suzuki; Y Ohde; M Nishimura; S Sasaki; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

4.  Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer.

Authors:  R Kessler; B Gasser; G Massard; N Roeslin; P Meyer; J M Wihlm; G Morand
Journal:  Ann Thorac Surg       Date:  1996-11       Impact factor: 4.330

5.  Prospective study of extended segmentectomy for small lung tumors: the final report.

Authors:  Koichi Yoshikawa; Noriaki Tsubota; Ken Kodama; Hiroyoshi Ayabe; Toshihiko Taki; Takashi Mori
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

6.  Proportion of ground-glass opacity on high-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis.

Authors:  Haruhisa Matsuguma; Kohei Yokoi; Masaki Anraku; Tetsuro Kondo; Yukari Kamiyama; Kiyoshi Mori; Keigo Tominaga; Yukio Tsuura; Satoshi Honjo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-08       Impact factor: 5.209

7.  Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Keisuke Hanioka; Chiho Ohbayashi; Noriaki Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2004-03       Impact factor: 5.209

8.  Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer.

Authors:  Tomoshi Tsuchiya; Satoshi Hashizume; Shinji Akamine; Masashi Muraoka; Sumihisa Honda; Koichi Tsuji; Shougo Urabe; Tomayoshi Hayashi; Naoya Yamasaki; Takeshi Nagayasu
Journal:  Chest       Date:  2007-05-15       Impact factor: 9.410

9.  Small adenocarcinoma of the lung. Histologic characteristics and prognosis.

Authors:  M Noguchi; A Morikawa; M Kawasaki; Y Matsuno; T Yamada; S Hirohashi; H Kondo; Y Shimosato
Journal:  Cancer       Date:  1995-06-15       Impact factor: 6.860

10.  Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence.

Authors:  J Ogawa; T Tsurumi; S Yamada; S Koide; A Shohtsu
Journal:  Cancer       Date:  1994-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.